Glaxo CFO Says Multibillion-Dollar M&A Not ‘on the Cards’

GlaxoSmithKline PLC, the U.K.’s largest drugmaker, isn’t considering large-scale acquisitions, Chief Financial Officer Simon Dingemans said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.